Fundraising FoxWilbe Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
ExpressionEditsexpressionedits.comMay 2024 · $13M
ExpressionEdits builds a computational platform, the Genetic Syntax Engine, that uses AI and intron-based transgene design to improve protein expression for therapeutic applications.
AI & Machine LearningBiotechDeep Tech
Dr. Liliana Antunes(Group Leader, RNA Technologies; Co-founder)Kärt Tomberg(CEO; Co-founder; Director)inProf. Allan Bradley(Co-founder; Non-Executive Director)
Co-investorsBlueYard CapitalHAWKTAILOctopus VenturesAcequia Capital (AceCap)Amino Collectiveredalpine
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.